Results 161 to 170 of about 10,879 (228)

Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection

open access: yesHepatology, 2017
K. Kowdley   +12 more
semanticscholar   +1 more source

Prevalence of resistance-associated substitutions (RAS) in hepatitis C virus in the Former Soviet Union countries. [PDF]

open access: yesBMJ Open Gastroenterol
Mustafa A   +6 more
europepmc   +1 more source

<i>RhoJ</i> promotes the progression of clear cell renal cell carcinoma via the TNF-α/NF-κB axis. [PDF]

open access: yesTransl Androl Urol
Feng J   +12 more
europepmc   +1 more source

Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir.

open access: yesGastroenterology, 2016
C. Sarrazin   +15 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy